King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Jean Paul Atallah
Dr. Jean Paul Atallah is a senior Consultant Medical Oncologist based in Riyadh, Saudi Arabia, specialising in general adult medical oncology with strong interests in soft tissue sarcoma, rare tumours, and solid-tumour chemotherapy. He is a productive medical oncology specialist Riyadh, Saudi Arabia with an extensive clinical and research record in sarcoma and solid-tumour care.
- Consultant oncologist at a leading national referral cancer centre.
- Extensive research record across medical oncology and sarcoma care.
- Expertise in pazopanib and targeted therapy for soft tissue sarcoma.
- Active contributor to immune-related adverse event literature in melanoma and AML.
- Experienced in treating international patients across the Gulf, Africa, and South Asia.
Qualifications & Credentials
Medical Degrees
- MD (Doctor of Medicine)
- Residency — Internal Medicine
Fellowships & Special Training
- Fellowship — Medical Oncology
- Advanced Training — Soft Tissue Sarcoma & Rare Tumours
Certifications & Accreditations
- Saudi Commission for Health Specialties (SCFHS) Registration
- Member — American Society of Clinical Oncology (ASCO)
- Member — European Society for Medical Oncology (ESMO)
Areas of Expertise
Major Conditions Treated
- Soft Tissue Sarcoma
- Undifferentiated Pleomorphic Sarcoma
- Leiomyosarcoma & Synovial Sarcoma
- Desmoid Tumour / Aggressive Fibromatosis
- Adamantinoma & Rare Bone Tumours
- Nasopharyngeal Cancer
- Melanoma (Advanced / Metastatic)
- Breast Cancer
- Colorectal Cancer
- NUT Carcinoma
Sub-specialties
- Soft Tissue Sarcoma Systemic Therapy: Expert in pazopanib and multi-line therapy for advanced soft tissue sarcoma — a trusted medical oncology specialist Riyadh, Saudi Arabia for rare and aggressive sarcoma subtypes.
- Rare & Orphan Tumours: Published work on adamantinoma, NUT carcinoma, and other orphan malignancies, with individualised multimodality treatment plans.
- Immune Checkpoint Inhibitor Therapy: Experience in managing advanced melanoma and solid tumours with checkpoint inhibitors, including monitoring and treatment of immune-related adverse events.
Advanced Procedures & Treatments
- Chemotherapy (IV & Oral Regimens)
- Targeted Therapy (Pazopanib, VEGF, EGFR, HER2, BRAF inhibitors)
- Immunotherapy (PD-1, PD-L1, CTLA-4 Checkpoint Inhibitors)
- Hormone Therapy for Breast Cancer
- Capecitabine Monotherapy for Recurrent Nasopharyngeal Cancer
- Molecular Profiling & Precision Oncology
- Clinical Trial Enrolment for Rare Tumours
- Palliative Care Integration
Professional Experience
Current Affiliation
- King Faisal Specialist Hospital & Research Centre (KFSHRC), Riyadh, Saudi Arabia — Consultant, Medical Oncology Section, Oncology Centre (Present)
Past Affiliations
- Information not publicly available.
Academic & Research Roles
- Faculty — KFSHRC Medical Oncology Fellowship Programme
- Member — KFSHRC Sarcoma & Rare Tumour Multidisciplinary Board
Key Achievements
- Extensive peer-reviewed publication record in medical oncology
- Leader on Saudi Arabia soft tissue sarcoma real-world outcomes research
- Co-author on regional studies in nasopharyngeal cancer and rare solid tumours
- Experience with international patients requiring complex systemic therapy
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- American Society of Clinical Oncology (ASCO)
- European Society for Medical Oncology (ESMO)
- Connective Tissue Oncology Society (CTOS)
- Saudi Oncology Society
Research & Publications
Published Papers (Selected)
- Alshamsan B, Badran A, Alshibany A, …, Elhassan T, Maraiki F, Elshenawy MA, Atallah JP. Real-World Outcome and Prognostic Factors of Pazopanib in Advanced Soft Tissue Sarcoma. Cancer Manag Res. 2021.
- Abdulwali SK, El-Sibai A, Ali SS, Arabi TZ, …, Atallah JP. Predictive and Prognostic Factors in NUT Carcinoma: A Systematic Review and Individual Patient Data Meta-Analysis. 2024.
- Alquaydheb HN, …, Atallah JP. Rare Case of Recurrent Adamantinoma of the Tibia: Limited Efficacy of Pazopanib as a Standalone Treatment. Case Rep Oncol.
Ongoing Research & Clinical Interests
- Soft tissue sarcoma systemic therapy outcomes in Saudi Arabia
- Rare tumour registry (NUT carcinoma, adamantinoma)
- Capecitabine monotherapy for recurrent nasopharyngeal cancer
- Colorectal cancer response and survival by tumour sidedness
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Medical Oncology Consultation | ₹1,500 – ₹3,500 | $18 – $42 |
| Chemotherapy (per cycle, regimen-dependent) | ₹25,000 – ₹1,80,000 | $300 – $2,160 |
| Targeted Therapy (per month, drug-dependent) | ₹60,000 – ₹3,50,000 | $720 – $4,200 |
| Immunotherapy (per cycle) | ₹90,000 – ₹2,80,000 | $1,080 – $3,360 |
| Tumour Marker / Molecular Profiling Panel | ₹8,000 – ₹60,000 | $96 – $720 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Jean Paul Atallah use in Medical Oncology treatment?
Dr. Jean Paul Atallah uses advanced systemic therapy options including targeted therapy (pazopanib, VEGF/EGFR/HER2/BRAF inhibitors), immunotherapy (PD-1, PD-L1, CTLA-4 inhibitors), precision oncology based on molecular profiling, and clinical-trial-based treatment for rare tumours. Cancer Rounds can coordinate a virtual pre-travel consultation for international patients.
2. What conditions does Dr. Jean Paul Atallah specialize in treating?
Dr. Jean Paul Atallah specialises in soft tissue sarcoma, rare tumours (NUT carcinoma, adamantinoma, desmoid tumours), nasopharyngeal cancer, melanoma, breast cancer, and colorectal cancer — making him a trusted medical oncology specialist Riyadh, Saudi Arabia for best cancer treatment and expert second opinions.
3. How do I book an appointment with Dr. Jean Paul Atallah?
Appointments with Dr. Jean Paul Atallah can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Jean Paul Atallah?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Jean Paul Atallah, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Jean Paul Atallah offer second opinions for Medical Oncology cases?
Yes. Second opinion consultations with Dr. Jean Paul Atallah can be arranged via Cancer Rounds for patients seeking an expert Medical Oncology review of rare tumour diagnosis, sarcoma management, and personalised systemic therapy options in Riyadh, Saudi Arabia.
